Hannelouise Kissow - Concepedia

Author

Hannelouise Kissow

University of Copenhagen ORCID

Also Known As

H. Kissow, H.L Kissow, Hanne-Louise Kissow, HanneLouise Kissow, Hannelouise Kissow

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

University of Copenhagen Novo Nordisk Foundation Rigshospitalet Copenhagen University Hospital Novo Nordisk (Denmark)

About

Hannelouise Kissow is an author at University of Copenhagen specializing in medicine, pathology, and gastroenterology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	611
2	Allergy	2	2	68
3	Education	1	1	25
4	Public Health	1	1	23
5	Biochemistry	1	1	88

Hannelouise Kissow

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Activation of GLP-1 receptors on vascular smooth muscle cells reduces the autoregulatory response in afferent arterioles and increases renal blood flow Elisa P. Jensen, Steen Seier Poulsen, Hannelouise Kissow, American Journal of Physiology-Renal Physiology	2015	132
Glucagon-Like Peptide-1 (GLP-1) Reduces Mortality and Improves Lung Function in a Model of Experimental Obstructive Lung Disease in Female Mice Niels‐Erik Viby, Marie S. Isidor, Katrine B. Buggeskov, Endocrinology	2013	129
Dipeptidyl Peptidase IV Inhibition Enhances the IntestinotrophicEffect of Glucagon-Like Peptide-2 in Rats and Mice**This study was supported by grants from The Danish Biotechnology Center for Signal-peptide Research, The Danish Medical Research Council, The Danish Medical Association Research Fund, The Novo Nordisk Foundation, and The Nordisk Research Foundation. Bolette Hartmann, Jesper Thulesen, Hannelouise Kissow, Endocrinology	2000	119
Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis Katrine D. Galsgaard, Marie Winther‐Sørensen, Cathrine Ørskov, American Journal of Physiology-Endocrinology and Metabolism	2017	112
Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice Hannelouise Kissow, Bolette Hartmann, Jens J. Holst, Regulatory Peptides Tumor BiologyMedicinePathologyCancer BiologyGlucagon-like Peptide-1	2012	91
The truncated metabolite GLP-2 (3–33) interacts with the GLP-2 receptor as a partial agonist Jesper Thulesen, Lotte Bjerre Knudsen, Bolette Hartmann, Regulatory Peptides Molecular PharmacologyMolecular PhysiologyBiochemistryG Protein-coupled ReceptorMedicine	2002	88
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial Rahim M. Naimi, Mark Hvistendahl, Lotte Hahn Enevoldsen, The Lancet. Gastroenterology & hepatology Functional Gastrointestinal DisorderShort Bowel SyndromeMedicineRandomised Phase 2Gastroenterology	2019	75
Luminal and parenteral TFF2 and TFF3 dimer and monomer in two models of experimental colitis in the rat Steen Seier Poulsen, Hannelouise Kissow, Kristine Juul Hare, Regulatory Peptides InflammationTff3 DimerMucosal ImmunologyImmunologyGastroenterology	2004	67
Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats Bolette Hartmann, Jesper Thulesen, Kristine Juul Hare, Regulatory Peptides InflammationDiabetesPhysiologyGastroenterologyImmunology	2002	65
Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis Hannelouise Kissow, Bolette Hartmann, Jens J. Holst, Gut	2012	64

Page 1